The conjugate vaccines market will register USD 14.8 billion at a CAGR of 9.9% during the forecast period 2023-2032.
The conjugate vaccine market continues to thrive, driven by increasing awareness of preventive healthcare and government initiatives for immunization programs worldwide. Growing incidences of infectious diseases such as pneumonia, meningitis, and influenza are...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian